Organogenesis (ORGO)
(Delayed Data from NSDQ)
$2.91 USD
-0.04 (-1.36%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $2.90 -0.01 (-0.34%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth B Momentum C VGM
Cash flow Statements
Fiscal Year End for Organogenesis falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 4.95 | 15.53 | 94.90 | 17.95 | -40.45 |
Depreciation/Amortization & Depletion | 23.45 | 18.03 | 16.68 | 7.47 | 9.43 |
Net Change from Assets/Liabilities | -18.07 | -34.08 | -37.71 | -26.16 | -9.67 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 20.60 | 25.38 | -11.89 | 7.55 | 7.16 |
Net Cash From Operating Activities | 30.92 | 24.86 | 61.98 | 6.80 | -33.53 |
Property & Equipment | -24.36 | -33.90 | -31.22 | -21.15 | -5.98 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | -5.82 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 2.13 | -0.25 |
Net Cash from Investing Activities | -24.36 | -33.90 | -31.22 | -24.83 | -6.23 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 2.07 | 2.20 | 2.82 | -5.87 |
Issuance (Repayment) of Debt | -5.17 | -3.01 | -0.39 | 48.82 | 88.49 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.33 | -1.26 | -2.84 | -9.17 | -3.90 |
Net Cash from Financing Activities | -5.51 | -2.20 | -1.04 | 42.47 | 78.73 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 1.05 | -11.24 | 29.72 | 24.44 | 38.97 |
Cash at Beginning of Period | 103.29 | 114.53 | 84.81 | 60.37 | 21.41 |
Cash at End of Period | 104.34 | 103.29 | 114.53 | 84.81 | 60.37 |
Diluted Net EPS | 0.04 | 0.12 | 0.71 | 0.16 | -0.44 |
Fiscal Year End for Organogenesis falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -2.10 | 4.95 | 5.51 | 2.35 |
Depreciation/Amortization & Depletion | NA | 6.18 | 23.45 | 17.12 | 11.27 |
Net Change from Assets/Liabilities | NA | -20.70 | -18.07 | -15.42 | -18.44 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 6.46 | 20.60 | 13.09 | 8.39 |
Net Cash From Operating Activities | NA | -10.16 | 30.92 | 20.30 | 3.57 |
Property & Equipment | NA | -2.22 | -24.36 | -21.04 | -15.06 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -2.22 | -24.36 | -21.04 | -15.06 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.18 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | -1.67 | -5.17 | -3.40 | -1.96 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -1.12 | -0.33 | -0.33 | -0.33 |
Net Cash from Financing Activities | NA | -2.61 | -5.51 | -3.73 | -2.29 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -14.99 | 1.05 | -4.47 | -13.78 |
Cash at Beginning of Period | NA | 104.34 | 103.29 | 103.29 | 103.29 |
Cash at End of Period | NA | 89.35 | 104.34 | 98.83 | 89.51 |
Diluted Net EPS | NA | -0.02 | 0.00 | 0.02 | 0.04 |